Centers for Disease Control and Prevention Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application | RFA PS15 00103CONT

Opportunity Information: Apply for RFA PS15 00103CONT

The Centers for Disease Control and Prevention (CDC) Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application is a federal grant continuation opportunity administered by the U.S. Department of Health and Human Services through the CDC (ERA system). It is specifically a continuation notice, meaning it is intended to support the next budget period of an already funded project rather than to fund brand-new applicants proposing a new standalone project. The focus of the work is tied to the Positive Health Check Evaluation Trial, which, based on the title and CDC program context, centers on evaluating an intervention aimed at improving health outcomes, engagement, or care processes, with the work categorized broadly under Health.

This opportunity is listed under Funding Opportunity Number RFA PS15 00103CONT and uses a cooperative agreement as the funding instrument. A cooperative agreement typically indicates that CDC expects to have substantial involvement in the funded activities compared to a standard grant. In practical terms, that usually means recipients carry out programmatic work while CDC provides technical guidance, coordination, and oversight related to implementation and evaluation, such as aligning evaluation methods, ensuring fidelity to the intervention model, monitoring progress against performance measures, and supporting dissemination of findings.

The opportunity is categorized as a continuation and is described as a noncompetitive continuation application for FY2017. Noncompetitive continuation generally means the award is not competed among new applicants in an open competition; instead, current awardees under the underlying funding announcement are invited (or required) to apply to continue funding into the next year, assuming satisfactory performance and the availability of appropriated funds. This structure is commonly used when a multi-year evaluation or demonstration project is underway and continuity is required to preserve study design integrity, maintain participating sites, and complete planned data collection and analysis.

Administrative details show the opportunity was created on February 12, 2017, with an original closing date of March 29, 2017. The CFDA number is 93.941, which identifies the federal assistance listing associated with this program area within HHS/CDC. The funding activity category is Health, consistent with CDCs mission and the stated evaluation focus. The listing notes an expected number of awards of 10, suggesting CDC anticipated continuing support for up to ten existing recipients or project components under the broader initiative.

The posted award ceiling is shown as 0, which in grant listings often signals that a single uniform maximum was not specified in the public synopsis, that the ceiling may vary by recipient based on the approved continuation budget, or that the amount is determined by prior award terms and the recipients approved workplan and funding availability. In continuation cooperative agreements, budgets are often negotiated annually and tied to progress, scope, and the remaining aims of the evaluation trial.

Eligibility is described as "Others (see text field entitled Additional Information on Eligibility for clarification)," which is a common way of indicating that eligibility is restricted and defined in the full announcement text. For a noncompetitive continuation, that typically means only current recipients under the parent funding announcement (in this case associated with PS15-00103) are eligible to submit, rather than the general public, states, or all nonprofits. In effect, the relevant audience is the existing cohort of awardees already conducting the Positive Health Check Evaluation Trial work.

Overall, this notice represents CDCs mechanism to keep an ongoing, multi-site evaluation trial moving through FY2017 under a cooperative agreement framework, with continued funding contingent on acceptable progress and compliance with CDC requirements. It is primarily administrative and program-continuity oriented rather than an open solicitation for new projects, and it signals that CDC expected to maintain roughly ten active awards as the evaluation work proceeded.

• The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Centers for Disease Control and Prevention Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.941.
• This funding opportunity was created on Feb 12, 2017.
• Applicants must submit their applications by Mar 29, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA PS15 00103CONT

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: